Relaxation effect of abacavir on rat basilar arteries.

Abstract

BACKGROUND:

The use of abacavir has been linked with increased cardiovascular risk in patients with human immunodeficiency virus infection; however, the mechanism involved remains unclear. We hypothesize that abacavir may impair endothelial function. In addition, based on the structural similarity between abacavir and adenosine, we propose that abacavir may affect vascular contractility through endogenous adenosine release or adenosine receptors in blood vessels.

METHODS:

The relaxation effect of abacavir on rat basilar arteries was studied using the myograph technique. Cyclic GMP and AMP levels were measured by immunoassay. The effects of abacavir on nucleoside transporters were studied using radiolabeled nucleoside uptake experiments. Ecto-5' nucleotidase activity was determined by measuring the generation of inorganic phosphate using adenosine monophosphate as the substrate.

RESULTS:

Abacavir induced the relaxation of rat basilar arteries in a concentration-dependent manner. This relaxation was abolished when endothelium was removed. In addition, the relaxation was diminished by the nitric oxide synthase inhibitor, L-NAME, the guanylyl cyclase inhibitor, ODQ, and the protein kinase G inhibitor, KT5820. Abacavir also increased the cGMP level in rat basilar arteries. Abacavir-induced relaxation was also abolished by adenosine A2 receptor blockers. However, abacavir had no effect on ecto-5' nucleotidase and nucleoside transporters. Short-term and long-term treatment of abacavir did not affect acetylcholine-induced relaxation in rat basilar arteries.

CONCLUSION:

Abacavir induces acute endothelium-dependent relaxation of rat basilar arteries, probably through the activation of adenosine A2 receptors in endothelial cells, which subsequently leads to the release of nitric oxide, resulting in activation of the cyclic guanosine monophosphate/protein kinase G-dependent pathway in vascular smooth muscle cells. It is speculated that abacavir-induced cardiovascular risk may not be related to endothelial dysfunction as abacavir does not impair relaxation of blood vessels. The most likely explanation of increased cardiovascular risk may be increased platelet aggregation as suggested by other studies.

• Authors: Rachel Wai Sum Li, Cui Yang, Shun Wan Chan, Maggie Pui Man Hoi, Simon Ming Yuen Lee, Yiu Wa Kwan, George Pak Heng Leung
• Journal: PloS one (PLoS One) Vol. 10 Issue 4 Pg. e0123043 ( 2015) ISSN: 1932-6203 [Electronic] United States
• PMID: 25853881 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Dideoxynucleosides
• Vasodilator Agents
• Adenosine Triphosphate
• Cyclic GMP
• abacavir

Topics

• Adenosine Triphosphate (metabolism)
• Animals
• Basilar Artery (drug effects, metabolism, physiopathology)
• Cardiovascular Diseases (drug therapy, physiopathology)
• Cyclic GMP (metabolism)
• Dideoxynucleosides (administration & dosage)
• Humans
• Muscle Contraction (drug effects)
• Muscle Relaxation (drug effects)
• Muscle, Smooth, Vascular (drug effects, metabolism)
• Myography
• Rats
• Risk Factors
• Vasodilator Agents (administration & dosage)